Skip to main content
Loading

Overcoming membrane protein complexes using display technologies [Topic TBC]

22 Sep 2025
Target Selection & Mechanisms of Action
  • How do we pair targets with the suitable MOA for the specific cell type and disease indication selected?
  • Do we need ’new’ targets, or new ways of targeting them?
  • Can we achieve truly disease-selective targeting?
Industry Expert
Danielle Dettling, CSO and Co-Founder - Fury Biosciences, LLC